The international community is currently reviewing how effective global HIV/AIDS programs are, as funding has become unstable and there is a new focus on allowing African nations to manage their own healthcare.

由於資金變得不穩定，且目前的重心轉向允許非洲國家管理自身的醫療保健，國際社會目前正在審視全球 HIV/AIDS 計畫的成效。

Data shows that HIV-related deaths and infections have dropped significantly since 2010. For example, deaths from pediatric AIDS fell by 69 percent, and twenty-two countries have stopped the transmission of the virus from mothers to children. However, sudden funding cuts in 2025 have caused serious problems for healthcare systems, leading to the end of medical contracts and a shortage of medicine. UNICEF and UNAIDS warn that if prevention and treatment services are reduced by 50 percent, millions of children in sub-Saharan Africa could face new infections or death by 2040.

數據顯示，自 2010 年起，HIV 相關的死亡人數與感染率大幅下降。例如，兒童愛滋病死亡率下降了 69%，且有 22 個國家已成功阻止病毒由母親傳給子女。然而，2025 年突然的資金削減對醫療體系造成了嚴重問題，導致醫療合約終止以及藥物短缺。UNICEF 與 UNAIDS 警告，如果預防與治療服務減少 50%，到 2040 年，撒哈拉以南非洲可能有數百萬名兒童將面臨新感染或死亡。

To address these issues, African countries have created the 'Common Africa Position' for the 2026 UN High-Level Meeting. This plan argues that the current system, which relies too much on foreign donors, is no longer effective. Instead, they are pushing for 'health sovereignty,' which means using their own national budgets to fund healthcare and integrating HIV care into general health services. Furthermore, they aim to produce 60 percent of their own health products by 2040 to ensure a steady supply of medicine and better pricing.

為了處理這些問題，非洲國家為 2026 年聯合國高級別會議制定了「非洲共同立場」。該計劃認為，目前過於依賴外國捐助者的系統已不再有效。相反，他們正推動「健康主權」，意即利用自身的國家預算資助醫療保健，並將 HIV 護理整合至一般醫療服務中。此外，他們的目標是在 2040 年前自行生產 60% 的醫療產品，以確保藥物供應穩定且價格更合理。

New technology is also changing how the disease is prevented. A new drug called Lenacapavir only requires two injections per year, which is a major improvement. While South Africa has started using this treatment, experts are concerned about the high cost and whether the supply will remain consistent. They emphasize that if patients stop receiving these powerful drugs, the virus could become resistant. Meanwhile, creating a vaccine remains difficult because the virus changes quickly, although a new trial in South Africa is being closely watched for success.

新技術也正在改變預防該疾病的方式。一種名為 Lenacapavir 的新藥一年僅需注射兩次，是一項重大進步。雖然南非已開始使用此治療，但專家擔心成本過高以及供應是否能維持穩定。他們強調，如果患者停止接受這些強力藥物，病毒可能會產生抗藥性。與此同時，由於病毒變異迅速，研發疫苗仍然困難，不過南非的一項新試驗正受到密切關注，期待能取得成功。

The global fight against HIV is at a turning point. The future of the epidemic will depend on whether African nations can become self-sufficient and whether new long-acting medicines can be distributed fairly.

全球對抗 HIV 正處於轉折點。疫情的未來將取決於非洲國家能否實現自給自足，以及新型長效藥物能否得到公平分配。